Your Cart
Loading

HEMATOLOGICAL MALIGNANCIES – COMPREHENSIVE MEDICAL ONCOLOGY NOTES

On Sale
₹99.00
₹99.00
Added to cart

🩸 HEMATOLOGICAL MALIGNANCIES – COMPREHENSIVE MEDICAL ONCOLOGY NOTES


Master the fundamentals and clinical management of five major hematological malignancies with the OncoNotes 2024 comprehensive notes collection.


📚 DISEASES COVERED


1️⃣ ACUTE MYELOID LEUKEMIA (AML)


- WHO and ICC classification

- ELN risk stratification

- Molecular and cytogenetic abnormalities

- Diagnosis and workup

- Intensive chemotherapy (7+3, CPX-351)

- Venetoclax-based regimens

- FLT3 and IDH inhibitors

- APL management

- Allogeneic stem cell transplantation

- Relapsed/refractory AML


2️⃣ CHRONIC MYELOID LEUKEMIA (CML)


- Pathophysiology and BCR::ABL1

- Diagnosis and disease phases

- ELN recommendations

- First-, second- and later-generation TKIs

- Molecular monitoring and response criteria

- Treatment-free remission

- TKI resistance and mutation analysis

- Management of TKI toxicities


3️⃣ CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)


- IWCLL diagnostic criteria

- Rai and Binet staging

- FISH and molecular prognostic markers

- TP53 and IGHV assessment

- Indications for treatment

- BTK inhibitors and BCL-2 inhibitors

- Fixed-duration versus continuous treatment

- Relapsed/refractory CLL

- Richter transformation


4️⃣ DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)


- Classification and molecular subtypes

- GCB versus ABC classification

- Diagnostic workup and staging

- IPI and CNS-IPI

- First-line treatment: R-CHOP and Pola-R-CHP

- CNS prophylaxis

- Primary refractory and relapsed disease

- CAR-T cell therapy

- Bispecific antibodies

- Important clinical trials


5️⃣ FOLLICULAR LYMPHOMA (FL)


- Classification and histological grading

- Diagnosis and staging

- FLIPI and FLIPI-2

- Indications for treatment

- Watchful waiting versus active treatment

- Rituximab-based regimens

- Bendamustine-based treatment

- Maintenance therapy

- Relapsed/refractory follicular lymphoma

- Targeted therapies and newer treatment approaches


🎯 WHAT MAKES THESE NOTES USEFUL?


✔️ Written in easy-to-understand language.

✔️ Systematically organised disease-wise.

✔️ Important information presented through structured text and summary tables.

✔️ Clinical approach to diagnosis and treatment.

✔️ Guideline-oriented content.

✔️ Important clinical trials and treatment concepts.

✔️ Useful for both conceptual learning and quick revision.


👨‍⚕️ WHO SHOULD READ THESE NOTES?


- DM/DrNB Medical Oncology residents and aspirants

- MD/DNB Radiation Oncology residents

- Clinical Oncologists

- Medical Oncologists

- Clinical Hematologists

- Residents preparing for oncology examinations


📖 OUR OBJECTIVE


To make complex hematological malignancies easier to understand by presenting extensive medical information in a structured, readable and clinically relevant format.


ONCONOTES 2024

Simplifying Medical Oncology, One Topic at a Time.


Total Pages: 96


You will get a PDF (638KB) file

Customer Reviews

There are no reviews yet.